![Marnix Bosch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 29 319 $ in data 31/05/2026
Marnix L.
Bosch currently works at Northwest Biotherapeutics, Inc., as Chief Technical Officer from 2000 and the University of Washington, as Affiliate Associate Professor.
Dr. Bosch also formerly worked at Rijksinstituut Voor Volksgezondheid En Milieu, as Head-Molecular Biology Department.
Dr. Bosch received his Masters Business Admin degree in 2003 from the University of Washington and doctorate degree in 1987 from the University of Leiden.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 14/11/2025 | 129.157 ( 0,01% ) | 29 319 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| NORTHWEST BIOTHERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2000 |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Società | Posizione | Fine |
|---|---|---|
Rijksinstituut Voor Volksgezondheid En Milieu | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Northwest Biotherapeutics, Inc.
 Northwest Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes immunotherapy products | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rijksinstituut Voor Volksgezondheid En Milieu |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
